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Abstract
Background: Breast cancer mortality has experienced important changes over the last century.
Breast cancer occurs in the presence of other competing risks which can influence breast cancer
incidence and mortality trends. The aim of the present work is: 1) to assess the impact of breast
cancer deaths among mortality from all causes in Catalonia (Spain), by age and birth cohort and 2)
to estimate the risk of death from other causes than breast cancer, one of the inputs needed to
model breast cancer mortality reduction due to screening or therapeutic interventions.
Methods:  The multi-decrement life table methodology was used. First, all-cause mortality
probabilities were obtained by age and cohort. Then mortality probability for breast cancer was
subtracted from the all-cause mortality probabilities to obtain cohort life tables for causes other
than breast cancer. These life tables, on one hand, provide an estimate of the risk of dying from
competing risks, and on the other hand, permit to assess the impact of breast cancer deaths on all-
cause mortality using the ratio of the probability of death for causes other than breast cancer by
the all-cause probability of death.
Results: There was an increasing impact of breast cancer on mortality in the first part of the 20th
century, with a peak for cohorts born in 1945–54 in the 40–49 age groups (for which approximately
24% of mortality was due to breast cancer). Even though for cohorts born after 1955 there was
only information for women under 50, it is also important to note that the impact of breast cancer
on all-cause mortality decreased for those cohorts.
Conclusion: We have quantified the effect of removing breast cancer mortality in different age
groups and birth cohorts. Our results are consistent with US findings. We also have obtained an
estimate of the risk of dying from competing-causes mortality, which will be used in the assessment
of the effect of mammography screening on breast cancer mortality in Catalonia.
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Background
Breast cancer is the leading cause of mortality among mid-
dle-aged women in many developed countries, including
Catalonia, a region in the northeast of Spain, where it
accounts for a fifth of all female cancer deaths and, on the
average, fourteen years of potential life lost per death from
this cause [1].
Causes of death other than breast cancer may influence
mortality trends in two ways: 1) by changing the number
of women at risk of having breast cancer and, 2) by chang-
ing the risk of dying of breast cancer once it has devel-
oped. For example, infectious diseases at the beginning of
the 20th century reduced the number of women at risk for
breast cancer and also competed with breast cancer as a
cause of death in women with this disease. Thus, the effect
of other causes of death in breast cancer incidence and
mortality has changed over time depending on trends in
other competing risks.
Rosenberg [2] used the multi-decrement life table meth-
odology to partition overall mortality into mortality due
to breast cancer and mortality due to other causes. In addi-
tion, multi-decrement life tables permit assessment of the
impact that breast cancer mortality has on overall mortal-
ity by birth cohort and age. For instance, in the US, the
reduction in overall mortality when removing breast can-
cer as a cause of death could be as high as 15% at some
ages.
Evaluation of the impact of mammography and adjuvant
therapy on breast cancer mortality reduction can be done
using statistical models, for example those found in sev-
eral studies sponsored by CISNET [3]. The modeling proc-
ess requires information such as the dissemination of
mammography and adjuvant treatment programs, diag-
nostic characteristics of mammography, breast cancer
incidence and mortality. Another required input is the
competing-cause mortality, taking into account that
deaths due to breast cancer occur in the presence of other
causes of death, the above-mentioned competing risks.
The aims of the present work are: 1) to assess the impact
of breast cancer mortality on overall mortality by birth
cohort and age in Catalonia in the 20th century and 2) to
assess the risk of death from other causes than breast can-
cer in cohorts born from 1900 to 2004. Our analysis is
based on Rosenberg's work for the US and is part of a
wider project that aims to model the impact of mammog-
raphy in Catalonia (Spain) based on the methodology
developed by Lee and Zelen for the CISNET project [4].
Methods
Data Sources
Catalonia is an autonomous region of Spain which has
had authority over health-care planning, administration
and provision since 1985. It has approximately one sixth
of the Spanish population. The Catalan Health Depart-
ment has implemented an independent information sys-
tem and preventive programs in the region. Population
breast cancer screening programs were initiated in the
early nineties [5].
By the year 2007, the Catalan Health Service was provid-
ing services to 7 million inhabitants, including 3.5 mil-
lion women. The female population grew from 800.000
women in 1900 to more than 3 million in 2004. The
number of breast cancer deaths increased from an average
of 612 per year in the period 1975–79 to 1060 per year in
the period 1990–94 and then decreased to an average of
1000 per year in the period 2000–04. For the same peri-
ods, the percentage of breast cancer deaths among overall
mortality in women increased from 3.5% to 5.2% and
then decreased to 3.6%.
Table 1 shows the data sources used in this study and
describes their characteristics. The National Institute of
Statistics (INE [6]) and the Catalan Institute of Statistics
(IDESCAT [7]) have provided estimations of annual pop-
ulation changes since 1970. These changes were estimated
by the component method [8] which takes into account
vital statistics (births and deaths) and immigration to
adjust official post-census estimates. We obtained the
Table 1: Description and sources of data.
Data Period Description Source
Population 1900–1970 Official census data (every 10 years) National Institute of Statistics (INE)
1970–1985 Annual population estimated by the components method* INE
1986–2004 Annual population estimated by the components method* Catalan Institute of Statistics (IDESCAT)
All-cause mortality 1900–1974 Annual counts INE
1975–2004 Annual counts Catalan Mortality Registry
Breast cancer mortality 1975–2004 Annual counts Catalan Mortality Registry
*For a detailed description of the component method see reference [8]BMC Cancer 2008, 8:331 http://www.biomedcentral.com/1471-2407/8/331
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mid-year population data using linear interpolation. Mor-
tality data has been officially collected and registered by
the Catalan Mortality Registry [9] and the INE. These two
institutions had this responsibility during different peri-
ods (see Table 1). Population and deaths correspond to
residents in Catalonia. All data are public and available
from their annual reports and web pages [6,7,9].
We grouped cohorts and ages into five-year categories in
order to smooth data and minimize fluctuations present
in some census and mortality data prior to 1960 [10], and
to get more reliable estimates for young age groups. We
used linear interpolation to estimate missing data or to
split categories that were larger than five years in the orig-
inal data source.
Statistical analysis
Deaths by calendar year were converted into deaths by
year of birth (cohorts) using the relation year of birth = cal-
endar year of death – age at death.
Actuarial life table methods were used to obtain the life
table functions: the age specific death rate nMx,BY, the con-
ditional probabilities of death nqx,BY, and the proportion
of expected survivors by age lx,BY [11]. These functions
were estimated for a) the overall population, and b) for a
population in which breast cancer had been eliminated as
a cause of death, in the following steps:
1) We obtained age-specific death rates, nMx,BY, for age
groups [x, x+n) and birth cohorts BY, using the expression:
where nDx,BY is the observed number of deaths and nKx,BY
the midyear population in age group x to x+n. In our anal-
ysis n is equal to 5 years.
2) We estimated overall probabilities of death nqx,BY in the
interval [x, x+n) with the formula:
where  nfx is the estimated fraction of years lived in the
interval. Assuming a uniform distribution of deaths over
time we have taken nfx = 0.5 for all age groups except the
0–4 age group, where nf0 = 0.4. All-cause probabilities of
death are labeled as  .
3) We estimated probabilities of death from breast cancer,
, in the interval [x, x+n) as described in Step 2, using
only breast cancer deaths in the numerator.
4) Probabilities of death in the last age group, 85+, were
estimated as   = 1 for overall mortality, and
 for breast cancer mortal-
ity.
5) We estimated the missing breast cancer mortality prob-
abilities for earlier years of birth using an age-cohort
model. The observed breast cancer death rates were used
to fit the following quasi-Poisson model that provides
maximum likelihood estimates of mortality rates (nMx,BY)
based on age (x) and year of birth (BY):
The age-cohort model parameters estimated using the
generalized linear models package of the R software [12]
were: β0: -1.59 × 103, βage1: 1.05, βage2: -2.06 × 10-2, βage3:
1.75 × 10-4, βage4: -5.21 × 10-7, βcohort1: 1.62, and βcohort2: -
4.2 × 10-4. Then the probabilities were estimated as
described in Step 2. Figure 1 shows the periods and age
groups where breast cancer mortality data was available
(in black) or estimated (in gray).
6) We subtracted the probabilities of dying from breast
cancer from the overall probabilities of death to obtain
the probabilities of dying from causes other than breast
cancer .
7) We obtained the life table function lx,BY, which indi-
cates the proportion of survivors at age x from birth cohort
BY, using the expression:
lx+n,BY = lx,BY (1 - nqx,BY), starting from l0,BY = 1
Following the same nomenclature used in probabilities of
death, the functions   and   were computed. The
 indicates the proportion of survivors from birth
cohort  BY, at the beginning of each age interval, after
removing breast cancer as a cause of death.
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8) We computed the ratio of  , which
measures the impact in all-cause mortality of removing
deaths from breast cancer at different birth cohorts and
ages. A ratio equal to 1, in a specific group, would indicate
that there is no breast cancer mortality in that group. A
ratio equal to 0 would indicate that all mortality is due to
breast cancer.
Results
Breast cancer impact on overall mortality
Cohort multi-decrement life table functions   and
 were obtained for a population of women born
between 1900 and 2004, with breast cancer removed as a
cause of death.
Figure 2 presents the ratio   by age and
cohort of birth. This ratio can be interpreted as the propor-
tion of deaths attributable to causes other than breast can-
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Breast cancer probabilities of death by age and year of birth, Catalonia (Spain) Figure 1
Breast cancer probabilities of death by age and year of birth, Catalonia (Spain). The black cells indicate the available 
data. The grey cells indicate data that are estimated using an age-cohort model. Years of birth are grouped in five-year intervals 
and are labeled with the first year of the interval.
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cer. It facilitates evaluating the impact of removing breast
cancer as a cause of death. Figures 2a and 2b show the
ratio before and after the extrapolation of breast cancer
probabilities of death, respectively.
The impact of removing breast cancer as a cause of death
is small under age 30 and over age 70. Below age 30 the
number of breast cancer cases is small and above age 70
mortality from other causes, such as cardiovascular dis-
eases, increases. The largest impact of removing breast
cancer as a cause of death in overall mortality is observed
at ages 40–54. For specific birth cohorts, the largest
observed impact was in the 40–44 age group for cohorts
born in 1945–49 and the 45–49 age group for cohorts
born in 1950–54 (24% of all-cause mortality for both
cohorts). Impacts assessed using observed data for cohorts
born after 1955 tended to decrease. This finding is further
supported by Figure 3, which shows the trend of breast
cancer mortality by age for five year periods from 1975–
79 to 2000–04. Breast cancer probability of death
increased in all age groups from 1975–79 to 1990–94. In
contrast, the last two studied periods, 1995–99 and 2000–
04, show a reduction in breast cancer risk of death. Fur-
thermore, Figure 4 shows how breast cancer mortality
probabilities increased until the early 1990s, and then
began to decrease, in all age groups.
Risk of death from other causes than breast cancer
The   function estimates the risk of death from other
causes when breast cancer is eliminated. The lx,BY function
denotes the expected number of survivors at age x. The
 values can be used as an estimation of the propor-
tion of survivors, up to age x, if breast cancer was elimi-
nated as a cause of death. As an illustrative example, Table
2 shows the values of   and   for cohorts born in the
years 1920–24, 1930–34, and 1940–44. As expected, the
 data show an increasing trend in the probability of sur-
viving to a specific age by birth cohort. For instance, the
proportion of survivors at age 20 was 75% for women
born in the early 1920s, and increased to 90% for women
born in the early 1940s.
The column Dif. in Table 2 contains the difference
 per 10,000 women. It can be interpreted as
the number of women saved up to age x from an initial
cohort of 10,000 women, when breast cancer is removed
as a cause of death. If there were no breast cancer deaths,
for each 10,000 women born in 1920–24 approximately
93 would have been saved before arriving at age 70, and
118 women for the cohort born in 1930–34.
Figure 2 and Table 2 show two different approaches to
evaluating trends in breast cancer mortality in the pres-
ence of other causes of death by age and cohort. The 
estimates competing-cause mortality, the ratio
 shows the impact of breast cancer over
global mortality, and   indicates the number of
women saved up to age x if breast cancer was removed as
a cause of death.
Discussion and conclusion
Our study shows that breast cancer mortality in Catalonia
has experienced important changes over the last century.
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There was an increasing impact of breast cancer on overall
mortality in the first part of the century, with a peak for
cohorts born in 1945–54 in the 40–49 age groups
(approximately 24% of mortality was due to breast cancer
in these age groups and cohorts). This increasing impact
could be explained by a decrease in mortality from other
causes of death and increased breast cancer incidence and
mortality due to changes in lifestyle and reproductive pat-
terns [13]. In Catalonia, mortality from all causes in
women has been decreasing an average of 1.6% per year
since 1978 [14], whereas breast cancer incidence
increased 2.2% per year between 1980–97 [15].
The subsequent decrease in impact was due, primarily, to
the observed reduction in mortality from breast cancer
during the 1990s, which affected all age groups (see [16]
and official reports by the Catalan Department of Health
[14]). Furthermore, the significant reduction in recent
decades implies important gains in life expectancy for
middle-aged women [17]. This reduction has been attrib-
uted to the use of mammography and adjuvant treatments
in the US [18]. The phenomenon is now being studied in
Catalonia.
In Catalonia, as in the US, breast cancer mortality had the
greatest impact on global mortality in the 40–54 age
groups during the 20th century [2]. On one hand, breast
cancer incidence and mortality are low before the age of
40 [19]. Although breast cancer incidence and mortality
increase with age, after age 50 there are other causes of
death (competing risks) that are acting simultaneously,
and therefore breast cancer may have less impact on over-
all mortality.
It is worthwhile to note that the values of the ratio
 were higher in the US, which means that
the impact of breast cancer mortality was lower. The ratio
 depends on two risks, the risk of dying of
causes other than breast cancer (numerator) and the risk
of dying of any cause (denominator). For cohorts of
women born in the middle of the 20th century, overall
mortality rates at ages 40 to 54 years were 40% to 60%
higher in the US than in Catalonia [20]. On the other
hand, breast cancer mortality rates for these ages and
cohorts were similar or slightly higher in Spain than the
US. Since breast cancer mortality rates represent about
one fifth of the mortality in these age groups, differences
in the overall mortality risk in the US and Catalonia may
explain the differences seen in the   ratio.
But, other factors like reproductive patterns, hormonal
replacement therapy use and fat intake could explain dif-
nx B Y
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nx B Y qq    ,,
− t
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− t
nx B Y
bc
nx B Y qq    ,,
− t
Table 2: Proportion of survivors,  , and proportion of survivors after removing breast cancer as a cause of death,  , by age x and 
cohort of birth.
Ages Year of Birth
1920–24 1930–34 1940–44
Dif.* Dif.* Dif.*
20–24 0.7474 0.7474 0 0.8499 0.8499 0 0.8977 0.8977 0
25–29 0.7338 0.7338 0.14 0.8435 0.8435 0.17 0.8953 0.8953 0.17
30–34 0.7229 0.7230 0.83 0.8389 0.8390 0.97 0.8927 0.8928 0.97
35–39 0.7162 0.7165 3.00 0.8346 0.8350 3.56 0.8894 0.8897 3.20
40–44 0.7096 0.7104 7.91 0.8288 0.8297 9.42 0.8854 0.8862 8.20
45–49 0.7017 0.7034 16.45 0.8218 0.8236 17.74 0.8803 0.8821 17.65
50–54 0.6913 0.6941 28.61 0.8129 0.8159 30.16 0.8730 0.8762 32.23
55–59 0.6760 0.6800 39.65 0.8016 0.8064 48.20 0.8620 0.8675 54.90
60–64 0.6574 0.6630 56.01 0.7853 0.7924 70.91 0.8481 0.8557 76.17
65–69 0.6342 0.6414 72.63 0.7634 0.7731 96.93 - - -
70–74 0.6001 0.6094 93.00 0.7320 0.7438 117.75 - - -
7 5 – 7 9 0 . 5 4 9 9 0 . 5 6 1 2 1 1 2 . 9 5 ----- -
8 0 – 8 4 0 . 4 7 3 3 0 . 4 8 5 9 1 2 5 . 8 5 ----- -
8 5 + -------- -
Note:   can be interpreted as the proportion of women at risk of dying from competing risks at age x.
* Indicates the number of women saved up to age x from an initial cohort of 10,000 women, if breast cancer was removed as a cause of death.
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ferences in the impact of breast cancer mortality in both
countries.
Results from Rosenberg show that the lowest
 ratio (the highest impact of breast cancer
mortality) for women born in 1930 occurs at older ages
than for those born in 1950. This pattern is also shown in
our data before any extrapolation (Figure 2a). In Catalo-
nia this is related with a clear period effect during the
1990s. As we show in Figures 3 and 4, trends for breast
cancer death probabilities by age increased from the
1970s to the 1990s and started a decreasing trend after
that for all age groups.
The declines in mortality from breast cancer, which began
in Europe in the late 1980s may be attributed in part to
earlier detection by screening programs. But, since the
declining trends started before screening was introduced
and occurred also in non-screened age groups, improved
cancer treatments such as adjuvant chemotherapy and
tamoxifen may have been important determinants of
breast cancer mortality reduction [21]. In Catalonia,
breast cancer mortality started to decrease at the begin-
ning of the 1990s, concurrent with the dissemination of
mammography. Since the effect of screening would be
seen some years later, treatments probably had an impor-
tant role during the 1990s. The contribution of each of
these factors still needs to be determined in Catalonia.
Our work was undertaken in the Catalan region and not
in the whole country of Spain. This is due to the fact that
there is no national cancer registry in Spain. Instead, there
are 12 local cancer registries, which show differences in
the incidence of breast cancer by region (probably due to
different reproductive patterns and degrees of economic
development). The only statistics that are collected in a
standardized manner at the national level are mortality
data. Also, this study is part of a project that aims to assess-
ing the cost-effectiveness of different early detection strat-
egies on the reduction of breast cancer mortality. The cost-
effectiveness analysis needs information on outcomes and
costs that would be difficult to obtain at the national level.
On the other hand, since Catalonia has approximately
one sixth of the Spanish population, we believe that some
of the results of our studies will be relevant for all of
Spain.
This study has several limitations. First, the multi-decre-
ment method that we used assumes independence of
causes of death, which means that when breast cancer
mortality is removed, the risk of dying due to the remain-
ing causes of death is not affected. This assumption may
not be true, since different causes of death may share the
same risk factors. For example, body weight, smoking,
and diet are associated not only with breast cancer but
also with other health problems, like cardiovascular dis-
eases. Therefore, the probability of dying of other causes
could change when breast cancer death is removed. In our
study, if mortality from other causes had decreased when
eliminating breast cancer mortality, the impact of breast
cancer mortality would be higher than the reported val-
ues. There are methods for competing risks analysis, such
as cumulative incidence functions, that do not make any
assumptions about independence of risks, but need infor-
mation on the relationships among them [22,23]. These
methods are more complex than multi-decrement life
tables and have been used to evaluate the effects of
explanatory variables, such as assessing the effects of ther-
apy in different groups with multiple endpoints. On the
other hand, Chin Long Chiang proposed a method [24]
that takes into account different conditional probabilities
of death (crude, net and partial crude) which reflect the
relationships among the different risks of death acting
simultaneously. Nevertheless, although these methods
could be more accurate than the one used in our work,
they make assumptions about the risks' associations
requiring information that was not available to us such as
causes of death for women with breast cancer. Therefore,
we chose the multi-decrement method, that Rosenberg
also used [2], because it is simple and adequate to fulfill
our objectives.
A second limitation concerns quality of information. The
validity of population and mortality data has increased
over time, but there may be errors in data from the earliest
years of the study. We observed some fluctuations in the
late 1930s and early 1940s, coinciding with the Spanish
Civil War, a problem that could be addressed by smooth-
ing the life table series' before using them in subsequent
analyses. Also, to minimize variability we aggregated data
in 5-year age groups and calendar years. The quality of
mortality statistics has also changed over time, but differ-
ent studies have shown that in Spain, deaths from cancer
as a whole and leading cancer sites (lung, colon-rectum,
prostate, stomach, pancreas, female breast, uterus, brain,
leukemia, lymphomas and myeloma) were properly
coded [25,26]. Furthermore, breast cancer mortality data
was provided by the Catalan Mortality Registry which,
since the beginning of the 1980s, collects data and codes
causes of death consistently and has adequate quality
standards.
A third limitation arises from the assumptions made
when completing information on breast cancer mortality
probabilities for years without available data. Data from
available years seemed adequate to us to fit an age-cohort
model that predicted missing information. Other approx-
imations such as the assumption that the probabilities of
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dying from breast cancer at a given age would be the same
in neighboring years with data, as Rosenberg did, do not
change the main results (data not shown). In any case,
extrapolated data for the earlier cohorts may differ from
the actual values and therefore results based on these data
should be interpreted with caution.
In summary, we obtained cohort life tables for causes of
death other than breast cancer in Catalonia (Spain). This
makes it possible to quantify the impact of removing
breast cancer on overall mortality in different age groups
and birth cohorts ( ). As with the US
results, our analysis found that the greatest impact of
breast cancer mortality on overall mortality was for
women aged 40–54 born in the middle of the 20th cen-
tury. The multi-decrement life tables method also pro-
vided estimations of the risk of dying from competing
risks that will be used in the assessment of the effect of
mammography screening on breast cancer mortality.
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